NiNA
Overactive Bladder (OAB)
Pre-clinicalActive
Key Facts
About EBT Medical
EBT Medical is pioneering a novel approach to treating pelvic health disorders by targeting the saphenous nerve, a newly discovered pathway for neuromodulation. Its lead program, NiNA, is a non-invasive neurostimulator and digital ecosystem for overactive bladder (OAB), designed to be an early-line therapy that avoids the side effects of drugs and the invasiveness of existing procedures. The company is venture-backed by firms like SV Health Investors and Genesys Capital and is led by a team with deep experience in medical devices and neuromodulation. EBT aims to disrupt the large but underserved OAB market by shifting neuromodulation from a last-resort treatment to a primary therapeutic option.
View full company profileTherapeutic Areas
Other Overactive Bladder (OAB) Drugs
| Drug | Company | Phase |
|---|---|---|
| Weekly Microneedle Patch for Overactive Bladder | TSRL Inc | Pre-clinical |
| Overactive Bladder Program | Evestra | Pre-clinical/Clinical |
| MedRing for Overactive Bladder | LiGalli | Pre-clinical/Early Clinical |